Out of the available etching and bonding techniques, clinicians often choose total-etch systems. Clear advantages of this technique include predictably high bond strengths to enamel and dentin and a lack of interference with polymerization of dual-cure resin products. However, this approach isn’t without its challenges. When total-etching, improper technique (such as over-etching and undesirable dentinal wetness) can lead to uncomfortable and costly after-effects—post-operative sensitivity is a possibility as is, paradoxically, decreased bond strengths.
Given the challenges associated with etching and bonding, manufacturers have sought to create ways to improve procedural outcomes. With the introduction of MPa™ MAX, industry innovator Clinician’s Choice® has developed a solution to common adhesive woes. MPa MAX is a total-etch adhesive system designed to maximize bond strength while preventing post-operative sensitivity. With MPa MAX, practitioners can expect better clinical outcomes alongside improved patient comfort and satisfaction.
MPa MAX is a fifth-generation total-etch adhesive that provides predictable quality, long-lasting bond strengths across an array of indications. The product produces the highest bond strength to dentin, enamel, zirconia and lithium disilicate.[1] With its viscous consistency, MPa MAX is easy to use and requires only one application on each adhesive wall to fully seal dentin and enamel. Due in large part to readily observable indicators at the solvent evaporation stage, MPa MAX resists over-thinning and no cases of post-operative sensitivity have been reported.[1]
In addition to reliably coating and sealing dentinal tubules, thus preventing intratubular fluid flow, MPa MAX combats post-operative sensitivity with the help of G5 All-Purpose Desensitizer. Included in the MPa MAX kit, G5 is a clinically-proven glutaraldehyde-based desensitizer placed after etching and before application of MPa MAX. G5 works in conjunction with MPa MAX to seal dentin by coagulating intratubular proteins. This critical step prevents stimulation of the odontoblastic processes along with any chance of post-operative sensitivity.
While research shows that most bonding agents lose up to 50% of their bond strength within the first six months, MPa MAX is formulated to deliver years of retention.1 Metalloproteinases (MMP) enzymes activated during the etching process can result in degradation of the adhesive bond. As one of the few adhesives to contain 0.2% Chlorhexidine (CHX), an antiseptic agent, MPa MAX counters MMP activation and helps retain bond strengths for years to come.
To learn more about MPa MAX and order the product for your practice, visit Clinician’s Choice’s website.
[1] https://www.clinicianschoice.com/marketing/CCI19_SS_MPaMax_Intl.pdf